Key statistics
On Friday, Climb Bio Inc (CLYM:NMQ) closed at 5.02, 113.62% above the 52 week low of 2.35 set on Dec 11, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.87 |
---|---|
High | 5.10 |
Low | 4.86 |
Bid | 4.70 |
Offer | 5.58 |
Previous close | 4.86 |
Average volume | 345.80k |
---|---|
Shares outstanding | 67.06m |
Free float | 60.10m |
P/E (TTM) | -- |
Market cap | 336.64m USD |
EPS (TTM) | -2.15 USD |
Data delayed at least 15 minutes, as of Oct 18 2024 21:00 BST.
More ▼
Announcements
- Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
- Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
- Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19
- Climb Bio to Host Virtual Investor Event on October 15, 2024
- Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
- Eliem Therapeutics Announces Additions to its Leadership Team
- Eliem Therapeutics Reports Second Quarter Financial Results
- Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
- Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
More ▼